Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
0.860
-0.047 (-5.14%)
At close: Feb 21, 2025, 4:00 PM
0.910
+0.049 (5.75%)
After-hours: Feb 21, 2025, 7:57 PM EST
Tempest Therapeutics Market Cap
Tempest Therapeutics has a market cap or net worth of $37.55 million as of February 21, 2025. Its market cap has decreased by -52.76% in one year.
Market Cap
37.55M
Enterprise Value
33.17M
1-Year Change
-52.76%
Ranking
Category
Stock Price
$0.86
Market Cap Chart
Since June 28, 2021, Tempest Therapeutics's market cap has decreased from $88.65M to $37.55M, a decrease of -57.64%. That is a compound annual growth rate of -20.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 37.55M | 3.10% |
| Dec 31, 2024 | 36.42M | -57.00% |
| Dec 29, 2023 | 84.69M | 600.22% |
| Dec 30, 2022 | 12.09M | -66.85% |
| Dec 31, 2021 | 36.49M | -58.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |